ON! Nicotine Pouches: Ownership, Product Lines & U.S. FDA Status
A dated guide to ON! ownership, original on! and on! PLUS U.S. listings, manufacturer records and the limits of catalogue information.
Quick answer.
ON! and on! PLUS are commercialized through Helix Innovations, an Altria operating company. Altria identifies Helix Innovations as its operating company. FDA's authorized nicotine pouch list lists both original on! and on! PLUS entries as read on 8 October 2026. The six PLUS products remain the subject of the 19 December 2025 order; that dated scope is separate from the other listed on! products. Listing is not FDA approval or a local availability certificate. If you do not use nicotine, do not start.
Who owns ON!?
Altria announced an agreement to acquire 80% of the relevant global on! business in 2019. Altria says transactions for the remaining 20% closed in December 2020 and April 2021, and that on! and on! PLUS are commercialized through Helix Innovations. Altria documents those ownership and commercialization statements.
The 19 December 2025 FDA marketing-order appendix identifies Helix Innovations LLC as applicant and U.S. Smokeless Tobacco Company LLC as product manufacturer for the six specified PLUS products. Altria’s 23 March 2026 release attributes on! PLUS manufacture to Helix. These dated accounts concern different records; neither verifies the exact local can’s legal maker, importer or factory, which remain Unknown. Read the FDA marketing-order appendix.
on! and on! PLUS are distinct product families.
Altria Science describes on! PLUS as using proprietary NICOSILK mesh for product comfort. Read Altria Science's modern oral nicotine pouch overview. This attributed description does not establish composition, delivery performance, or a comparison with another product.
Six U.S.-authorized on! PLUS products.
The 19 December 2025 order covers six specific on! PLUS products for U.S. marketing: Mint 6 mg, Mint 9 mg, Tobacco 6 mg, Tobacco 9 mg, Wintergreen 6 mg, and Wintergreen 9 mg. The appendix states mg per pouch for these ordered products, not a universal unit for every market or catalogue number. The FDA public nicotine pouch list identifies the authorized products, and the marketing-order appendix records the ordered products.
The FDA list read on 8 October 2026 also names original on! Autumn Spice, Cappuccino and Rich Berry, each at 2 mg and 4 mg. These six original on! entries are distinct from on! PLUS. They do not establish new PLUS variants, worldwide stock or an exact local label match. Recheck the linked regulator list when this dated summary is used.
What FDA authorization means and does not mean.
FDA authorization applies only to the specified U.S. products. It is not FDA approval or a safety finding, and it does not authorize modified-risk claims. FDA's public list explains that authorization to market a tobacco product does not mean the product is safe or FDA approved, and the marketing-order appendix records the ordered products. It does not establish safety or availability outside the United States.
Where to check current SnusFriend catalogue status.
For SnusFriend product information, consult the ON! catalogue page. Check the product page for current availability. Exact local identity, amount units, portions, ingredients, packaging, availability, fulfilment and eligibility remain Unknown until the matching evidence is checked. Neither U.S. authorization nor a historical retail announcement establishes those facts.
Five visible FAQs.
Who owns and commercializes ON!?
ON! and on! PLUS are commercialized by Helix Innovations, an Altria operating company. Altria completed its acquisition of the global on! business through transactions that closed in 2020 and 2021.
Which on! PLUS products are authorized for U.S. marketing?
The 19 December 2025 FDA order covers on! PLUS Mint, Tobacco and Wintergreen at 6 mg and 9 mg. Its appendix states mg per pouch for those products. The FDA list read on 8 October 2026 also includes original on! Autumn Spice, Cappuccino and Rich Berry at 2 mg and 4 mg. Those original on! entries are a separate family, not additional PLUS variants or proof of local availability.
Is FDA marketing authorization the same as FDA approval?
No. FDA says authorization does not make a product safe or FDA approved. Nicotine is addictive, and nicotine pouches are not risk-free. If you do not use nicotine, do not start.
Does U.S. authorization establish ON! availability outside the United States?
No. U.S. marketing authorization concerns specified U.S. products. The ON! catalogue page provides SnusFriend product information for catalogue navigation; check the product page for current availability. Exact local availability, fulfilment, eligibility and package facts remain Unknown pending separate verification.
What is NICOSILK?
Altria Science describes on! PLUS as using proprietary NICOSILK mesh for product comfort. This source does not establish a quantified delivery-speed claim or silk-based composition.
Primary sources.
Last reviewed: 8 October 2026. Originally published 29 March 2026. Missing local package and operational evidence remains Unknown.
This article is for informational purposes only and does not constitute medical advice. Nicotine is an addictive substance. If you have health concerns about nicotine use, consult a qualified healthcare professional.